Evaluating Implementation and Impact of the Adapted Choose to Move (CTM) Program
Launched by UNIVERSITY OF BRITISH COLUMBIA · Feb 1, 2024
Trial Information
Current as of July 24, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Choose to Move (CTM) a 3-month, choice-based health-promoting program for low active older adults being scaled-up in phases across British Columbia (BC), Canada. To date (Phases 1-4), CTM participants have included mostly white older women living in large urban centres. In Phase 5, the investigators aim to expand the reach of CTM to three target populations: South Asian older adults, older men, and older adults living in Northern BC.
Within CTM (Phase 5), trained activity coaches support older adults in two ways. First, in a one-on-one consultation, activity coaches help participants to se...
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Central support unit staff member;
- • Delivery partner organization staff member;
- • Activity coach hired by delivery partner organization (activity coaches must speak English to participate in the evaluation);
- • English-speaking older adults (aged \>=50 years) who participate in CTM (recruited by delivery partner organizations) will be invited to participate in the evaluation;
- • Punjabi-speaking older adults will also be invited to participate in the evaluation if they can read English or Punjabi and/or if the activity coach or a member of the research team has the necessary language skills to ensure effective communication of the Punjabi language translated consent form and surveys.
- Exclusion criteria:
- • non-English speaking delivery partner staff member
- • non-English speaking activity coach
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Heather A McKay, PhD
Principal Investigator
University of British Columbia
Joanie Sims Gould, PhD
Principal Investigator
University of British Columbia
Dawn Mackey, PhD
Principal Investigator
Simon Fraser University
Farinaz Havaei, RN, PhD
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported